Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuai Sammy Yuan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Contemporary Clinical Trials|July 1, 2020
Meta-analysis of blinded and unblinded studies for ongoing aggregate safety monitoring and evaluationLi-An Lin, Shuai Sammy Yuan, Lie Li, et al.
Contemporary Clinical Trials|July 2, 2019
Bridging blinded and unblinded analysis for ongoing safety monitoring and evaluationLi-An Lin, Yilei Zhan, Hal Li, et al.
Contemporary Clinical Trials|October 22, 2020
Bayesian hierarchical model for safety signal detection in multiple clinical trialsYafei Zhang, Shuai Sammy Yuan, Barry A Eagel, et al.
Statistical Methods in Medical Research|April 11, 2022
Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indicationLinchen He, Yuru Ren, Han Chen, et al.
Contemporary Clinical Trials|March 6, 2018
Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysisKan Li, Shuai Sammy Yuan, William Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2023
Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysisJoseph Ficek, Eleftheria Kalaitzaki, Shuai Sammy Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical ConsiderationsChengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Contemporary Clinical Trials|July 1, 2020
Meta-analysis of blinded and unblinded studies for ongoing aggregate safety monitoring and evaluationLi-An Lin, Shuai Sammy Yuan, Lie Li, et al.
Contemporary Clinical Trials|July 2, 2019
Bridging blinded and unblinded analysis for ongoing safety monitoring and evaluationLi-An Lin, Yilei Zhan, Hal Li, et al.
Contemporary Clinical Trials|October 22, 2020
Bayesian hierarchical model for safety signal detection in multiple clinical trialsYafei Zhang, Shuai Sammy Yuan, Barry A Eagel, et al.
Statistical Methods in Medical Research|April 11, 2022
Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indicationLinchen He, Yuru Ren, Han Chen, et al.
Contemporary Clinical Trials|March 6, 2018
Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysisKan Li, Shuai Sammy Yuan, William Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2023
Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysisJoseph Ficek, Eleftheria Kalaitzaki, Shuai Sammy Yuan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2023
Tumor-Agnostic Approvals: Insights and Practical ConsiderationsChengxing Cindy Lu, Robert A Beckman, Xiaoyun Nicole Li, et al.
Therapeutic Innovation & Regulatory Science|February 3, 2020
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect HeterogeneityGang Li, Hui Quan, Gordon Lan, et al.
Pageof 1